Jin Medical International Completes 1-for-20 Reverse Stock Split to Maintain Nasdaq Listing

summarizeSummary

Jin Medical International Ltd. has completed a 1-for-20 reverse stock split and reclassified its share capital, effective March 16, 2026, to comply with Nasdaq listing requirements.

check_boxKey Events

• Reverse Stock Split Effective

  The company's 1-for-20 reverse stock split became effective on March 16, 2026, reducing outstanding Class A shares from 136,547,100 to 6,827,355 and Class B shares from 20,000,000 to 1,000,000.

• Nasdaq Compliance Initiative

  The reverse split is a strategic measure to maintain compliance with Nasdaq's continued listing requirements, specifically addressing the minimum bid price rule.

• Share Capital Reclassification

  Concurrently, the company reclassified its share capital into Class A and Class B ordinary shares, a change also effective March 16, 2026.

auto_awesomeAnalysis

Jin Medical International Ltd. has completed a 1-for-20 reverse stock split, effective March 16, 2026, as a strategic measure to maintain compliance with Nasdaq's continued listing requirements. This action, which significantly reduces the number of outstanding shares, is often viewed negatively by the market as it can signal underlying financial or operational challenges. Concurrently, the company reclassified its share capital into Class A and Class B ordinary shares, a structural change that may impact shareholder control dynamics.